Texas Medical Cannabis Patient Count Nears 150,000 Amid Expansion Delays
State's Compassionate Use Program enrollment surges as implementation of 2023 legislative reforms lags behind schedule.

Low angle shot of the historical Texas State Capitol building under a clear blue sky in Austin, TX.
Patient Enrollment Triples in Two Years
Texas's Compassionate Use Program now serves 149,847 registered patients, up from 48,000 in January 2024, marking the fastest growth period since the program's 2015 launch. The Texas Department of State Health Services reported the enrollment milestone in its May 2026 quarterly update, attributing the surge to expanded physician participation and gradual condition additions. The state currently licenses 87 prescribing physicians. That's up from 54 in early 2024.
The program permits low-THC cannabis products containing no more than 1% THC by weight for patients with qualifying conditions. Current qualifying diagnoses include epilepsy, multiple sclerosis, terminal cancer, autism, and PTSD, among others. The 2023 legislative session passed House Bill 1805, which authorized the Texas Health and Human Services Commission to add chronic pain, anxiety disorders, and certain sleep disorders to the qualifying condition list, but those additions haven't yet taken effect.
Implementation Delays Frustrate Patient Advocates
Rulemaking for the 2023 condition expansions remains pending 35 months after HB 1805's passage, with no finalized timeline from state regulators. The Health and Human Services Commission published a notice of proposed rulemaking in November 2024 but hasn't advanced the rules to final adoption. Agency spokespeople haven't provided a public explanation for the delay.
Patient advocacy groups say the stalled implementation leaves an estimated 200,000 Texans with chronic pain or anxiety disorders unable to access the program despite legislative authorization. The delay also affects the state's three licensed dispensing organizations, which have invested in cultivation and processing capacity in anticipation of the expanded patient base. One dispensary operator, speaking on background, estimated the delay has cost the industry $12 million in deferred revenue and delayed infrastructure investments.
Physician Participation Remains Narrow
Only 87 physicians hold active prescribing authority under the Compassionate Use Registry, representing 0.14% of Texas's 62,000 licensed doctors. Physicians must complete a state-approved training course and register with the Compassionate Use Registry to recommend low-THC cannabis. The Texas Medical Board hasn't mandated the training for broader physician categories. No medical schools in the state include cannabis therapeutics in their core curricula.
The narrow physician base concentrates in urban counties. Harris County accounts for 23 of the 87 registered prescribers, while 104 of Texas's 254 counties have no registered physician. Rural patients face average travel distances exceeding 120 miles to reach a prescribing doctor, according to a 2025 University of Texas Health Science Center analysis.
Dispensary Network Expands Slowly
The state's three licensed dispensing organizations now operate 18 retail locations statewide, up from 11 in 2024, but coverage gaps persist in West Texas and the Panhandle. State law caps the number of dispensing licenses at three, a restriction unchanged since the program's inception. The three license holders—Compassionate Cultivation, Goodblend Texas, and Surterra Wellness—have each opened additional storefronts under their existing licenses, but no new entrants have been authorized.
Legislative proposals to increase the license cap to ten have stalled in committee in both the 2023 and 2025 sessions. Industry observers attribute the stall to opposition from incumbent license holders and hesitancy among rural Republican lawmakers. The next opportunity for statutory change is the 2027 legislative session, which convenes in January.
What to Watch
The Health and Human Services Commission has scheduled a public hearing on the pending condition-expansion rules for July 15, 2026, the first formal proceeding since the November 2024 notice. Patient advocates are organizing testimony to press for expedited finalization. Separately, the Texas Medical Board is reviewing a petition from the Texas Cannabis Nurses Association to streamline physician training requirements, with a decision expected by September 2026. For full background on this story, see the CannIntel topic hub on the Texas Medical Cannabis Program.
For complete background, history, and our ongoing coverage of this story:
Open the CannIntel topic hub →Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws

Alabama Delays Automatic Marijuana Rescheduling Following Federal Shift
State officials invoke emergency rulemaking to halt state-law trigger tied to DEA rescheduling.

Canadian Tribunal Upholds Cannabis Ban for Flight Attendants
Employment board affirms airline's right to prohibit off-duty cannabis use under federal safety regulations.

New Jersey Advances Bill Expanding Hemp THC Beverage Sales in Liquor Stores
State lawmakers move forward legislation allowing licensed liquor retailers to sell hemp-derived THC beverages under new regulatory framework.
More from the newsroom

Tilray US Cannabis Entry Faces Regulatory and Capital Hurdles
Despite CEO optimism, Tilray Brands confronts Schedule III barriers, 280E tax penalties, and stretched balance sheet before any US THC play.

Jamaica Merges Ganja and Psilocybin Tourism in New Wellness Offerings
Resorts and herbalists now pair cannabis, psilocybin mushrooms, and steam-chalice rituals in legal wellness packages targeting international travelers.

The VPD cheat sheet every indoor cannabis grower needs
Vapor pressure deficit controls transpiration, nutrient uptake, and pathogen risk. Here are the numbers that matter, stage by stage, with the context to use them.